Long-term safety and efficacy of Omnitrope(®) in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study

PURPOSE: To report the long-term effectiveness and safety of the recombinant human growth hormone Omnitrope(®), a somatropin biosimilar to Genotropin(®), in Italian patients with growth hormone deficiency (GHD) enrolled in the PATRO Adults study. METHODS: The PATRO Adults study is an ongoing observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferone, D., Profka, E., Gasco, V., Ambrosio, M. R., Colao, A., Di Somma, C., Puxeddu, E., Arnaldi, G., Pagano, C., Zecchi, E., Pietropoli, A., Beck-Peccoz, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443881/
https://www.ncbi.nlm.nih.gov/pubmed/28161880
http://dx.doi.org/10.1007/s40618-016-0604-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443881/
https://www.ncbi.nlm.nih.gov/pubmed/28161880
http://dx.doi.org/10.1007/s40618-016-0604-8

Ejemplares similares